measuregroup/AID746834

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID174521656_AID746834_PMID23578690_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID123097261_AID746834_PMID23578690_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103173870_AID746834_PMID23578690_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103210760_AID746834_PMID23578690_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID174506275_AID746834_PMID23578690_VALUE4
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Therapeutic index, ratio of IC50 for human CD34-positive blood stem/progenitor cells to IC50 for human MA9.3 cells
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID174506275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103210760 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID123097261 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103173870 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID174521656
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID746834

Total number of triples: 14.